Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

<i>Background and Objectives</i>: Metabolic syndrome (MetS) is considered a global epidemic, and its diagnosis is crucial, allowing early intervention and management. The main aim of this study was to examine any possible blood pressure (BP) differences based on office and out-of-office...

Full description

Saved in:
Bibliographic Details
Main Authors: Christina Antza, Maria Sitmalidou, Andrej Belančić, Niki Katsiki, Vasilios Kotsis
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/3/434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850205268009287680
author Christina Antza
Maria Sitmalidou
Andrej Belančić
Niki Katsiki
Vasilios Kotsis
author_facet Christina Antza
Maria Sitmalidou
Andrej Belančić
Niki Katsiki
Vasilios Kotsis
author_sort Christina Antza
collection DOAJ
description <i>Background and Objectives</i>: Metabolic syndrome (MetS) is considered a global epidemic, and its diagnosis is crucial, allowing early intervention and management. The main aim of this study was to examine any possible blood pressure (BP) differences based on office and out-of-office measurements in patients with and without MetS, and to investigate if any of these measurements correlated better with MetS. The secondary aim was to investigate any possible cardiovascular risk differences. <i>Materials and Methods</i>: The study population consisted of individuals attending the outpatient hypertension clinic. Office and out-of-office BP measurements were recorded in all of the patients, as well as different cardiovascular risk scores and echocardiography. MetS was defined according to ACC/AHA criteria. <i>Results</i>: A total of 282 (39.9% men) individuals (56.8 ± 15.8 years) were analyzed; 60.8% of them had MetS. The patients with MetS had a significantly higher systolic BP (SBP) in all of the BP measurements, higher ASCVD risk (22% vs. 12%), Framingham risk scores (11.8% vs. 6.9%), a significantly higher prevalence of LVH (49.2% vs. 22.7%) and early vascular aging (54.8% vs. 27.4%) compared with the patients without MetS (<i>p</i> < 0.05 for all). In a univariate analysis, MetS was significantly correlated with the average 24h SBP, daytime and nighttime ambulatory SBP, office SBP, and home SBP in the morning (<i>p</i> < 0.05). No significant differences were observed for any of the DBP measurements. Finally, 50.5% of the MetS patients had sustained hypertension, 15.2% masked hypertension, and 11.5% white-coat hypertension based on ABPM, and these values were 45.1%, 19.3%, and 13.6%, respectively, based on HBPM. Furthermore, most of the MetS patients had non-dipping hypertension (56.4%). <i>Conclusions</i>: The present findings highlight the importance of out-of-office BP measurements in the diagnosis of MetS, since both a high office and out-of-office SBP were significant features of the syndrome (whereas this was not the case with DBP). This is further supported by the increased prevalence of different hypertension phenotypes observed in the MetS patients. Higher ASCVD risk scores and LVH and EVA prevalence were also related to MetS, thus strongly supporting the necessity for early detection and treatment.
format Article
id doaj-art-2b2fadea49ca44bcbf2a7bc432cfbab1
institution OA Journals
issn 1010-660X
1648-9144
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-2b2fadea49ca44bcbf2a7bc432cfbab12025-08-20T02:11:08ZengMDPI AGMedicina1010-660X1648-91442025-02-0161343410.3390/medicina61030434Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?Christina Antza0Maria Sitmalidou1Andrej Belančić2Niki Katsiki3Vasilios Kotsis43rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, Greece3rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, GreeceDepartment of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, CroatiaDepartment of Nutritional Sciences and Dietetics, International Hellenic University, 57400 Thessaloniki, Greece3rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, Greece<i>Background and Objectives</i>: Metabolic syndrome (MetS) is considered a global epidemic, and its diagnosis is crucial, allowing early intervention and management. The main aim of this study was to examine any possible blood pressure (BP) differences based on office and out-of-office measurements in patients with and without MetS, and to investigate if any of these measurements correlated better with MetS. The secondary aim was to investigate any possible cardiovascular risk differences. <i>Materials and Methods</i>: The study population consisted of individuals attending the outpatient hypertension clinic. Office and out-of-office BP measurements were recorded in all of the patients, as well as different cardiovascular risk scores and echocardiography. MetS was defined according to ACC/AHA criteria. <i>Results</i>: A total of 282 (39.9% men) individuals (56.8 ± 15.8 years) were analyzed; 60.8% of them had MetS. The patients with MetS had a significantly higher systolic BP (SBP) in all of the BP measurements, higher ASCVD risk (22% vs. 12%), Framingham risk scores (11.8% vs. 6.9%), a significantly higher prevalence of LVH (49.2% vs. 22.7%) and early vascular aging (54.8% vs. 27.4%) compared with the patients without MetS (<i>p</i> < 0.05 for all). In a univariate analysis, MetS was significantly correlated with the average 24h SBP, daytime and nighttime ambulatory SBP, office SBP, and home SBP in the morning (<i>p</i> < 0.05). No significant differences were observed for any of the DBP measurements. Finally, 50.5% of the MetS patients had sustained hypertension, 15.2% masked hypertension, and 11.5% white-coat hypertension based on ABPM, and these values were 45.1%, 19.3%, and 13.6%, respectively, based on HBPM. Furthermore, most of the MetS patients had non-dipping hypertension (56.4%). <i>Conclusions</i>: The present findings highlight the importance of out-of-office BP measurements in the diagnosis of MetS, since both a high office and out-of-office SBP were significant features of the syndrome (whereas this was not the case with DBP). This is further supported by the increased prevalence of different hypertension phenotypes observed in the MetS patients. Higher ASCVD risk scores and LVH and EVA prevalence were also related to MetS, thus strongly supporting the necessity for early detection and treatment.https://www.mdpi.com/1648-9144/61/3/434metabolic syndromeblood pressureatherosclerotic cardiovascular disease riskambulatory BPhome BPoffice BP
spellingShingle Christina Antza
Maria Sitmalidou
Andrej Belančić
Niki Katsiki
Vasilios Kotsis
Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
Medicina
metabolic syndrome
blood pressure
atherosclerotic cardiovascular disease risk
ambulatory BP
home BP
office BP
title Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
title_full Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
title_fullStr Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
title_full_unstemmed Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
title_short Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?
title_sort clinic ambulatory and home blood pressure monitoring for metabolic syndrome time to change the definition
topic metabolic syndrome
blood pressure
atherosclerotic cardiovascular disease risk
ambulatory BP
home BP
office BP
url https://www.mdpi.com/1648-9144/61/3/434
work_keys_str_mv AT christinaantza clinicambulatoryandhomebloodpressuremonitoringformetabolicsyndrometimetochangethedefinition
AT mariasitmalidou clinicambulatoryandhomebloodpressuremonitoringformetabolicsyndrometimetochangethedefinition
AT andrejbelancic clinicambulatoryandhomebloodpressuremonitoringformetabolicsyndrometimetochangethedefinition
AT nikikatsiki clinicambulatoryandhomebloodpressuremonitoringformetabolicsyndrometimetochangethedefinition
AT vasilioskotsis clinicambulatoryandhomebloodpressuremonitoringformetabolicsyndrometimetochangethedefinition